Eng
Sign In
Sign In / Sign Up

E-Poster

Introduction

E-Poster are electronic versions of posters that are usually presented in digital format, such as at conferences or exhibitions. They are similar to conventional posters in terms of content and purpose, but are presented in a digital format that allows for online sharing, with interactive features such as video, animation and hyperlinks. E-Poster can increase the attractiveness and interactivity of poster presentations, as well as allow users to easily share and store the information presented.

Guidelines for Writing E-Poster

E-Poster are uploaded via the website www.ilcbali2025.id. We do not accept revisions in any form after that date

  • 1E-Poster will be displayed on the LCD layer with the following conditions
    • Indonesian
    • Format: In JPG format (portrait orientation, 1 page)
    • Pixels: 19200 x 10805 pixels
    • Size: 165.56 x 91.48
    • Letters: Minimum size 16
    • File: 10-20 MB
    • Picture or table illustrations are informative and easy to understand
    • Does not support video or audio features
    • The color composition is harmonious and good
  • 2Research E-Poster and Case Reports must contain
    • Identification in the form of the names of the main and co-authors, as well as the institution of origin are included in full
    • The title is written in full capital letters
    • The research E-Poster consists of an Introduction / Background. Research Methods, Research Results, Discussion, Conclusions, and Bibliography / References
    • The case report E-Poster consists of an Introduction/Background, Case Report, Discussion, Conclusion, and Bibliography/References
  • 3The total number of bibliography on the E-poster is a maximum of 10 references
  • 4The presenter must bring a soft copy of the E-Poster

Submitted E-Poster

Author Title Action
Khunadi Hubaya The Efficacy Of Rifampicin and Clarithromycin Combination in The Management of Histoid Hansen’s and Lucio Phenomenon View
Bernard Naafs Have technological advances improved our understanding of immune responses and are they contributing to the development of vaccines and the treatment of leprosy reactions? View
Rizki Amelia Noviyanthi High Mobility Box Group-1 (HMGB-1) as Potential Biomarker to Erythema Nodosum Leprosum (ENL) of Leprosy View
ANA CARLA PEREIRA LATINI Pharmacogenetics of leprosy in the Brazilian population: the role of drug transporter genes. View
Alex Frank Raulim Leprosy Case Burden in Major Cities in Bangladesh View
Antonio García Belmar Fontilles Heritage Project: Empowering Dignity and Challenging Stigma through a radical empathy and agonistic approach to leprosy heritage preservation and dissemination. View
Shutiwan Ponladech A study of the leprosy surveillance system in Report D506 using the leprosy case reporting system of the Rajpracha samasai Institute as the reference database between January 1 and October 8, 2023 View
Pojana Thanyakittikul Development of a practical guideline for evaluating the standards of national leprosy node. View
Dr Rishad Choudhury Robin Psychological Distress Among Women in Leprosy-Affected Households in Northern Bangladesh: Depression, Anxiety, and Stress View
Anil Fastenau Roadmap towards Zero Leprosy in Pakistan: 2025–2030. View